Go Pro

AbCellera Biologics (ABCL) Institutional Ownership

AbCellera Biologics logo
$13.74 -0.17 (-1.22%)
Closing price 04:00 PM Eastern
Extended Trading
$13.80 +0.06 (+0.44%)
As of 06:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for AbCellera Biologics (NASDAQ:ABCL)

Current
Institutional Ownership
Percentage
61.42%
Number of
Institutional Buyers
(last 12 months)
77
Total
Institutional Inflows
(last 12 months)
$189.18M
Number of
Institutional Sellers
(last 12 months)
29
Total
Institutional Outflows
(last 12 months)
$67.90M
Get ABCL Insider Trade Alerts

Want to know when executives and insiders are buying or selling AbCellera Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ABCL Institutional Buying and Selling by Quarter

AbCellera Biologics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026WINTON GROUP Ltd56,300$442K0.0%N/A0.018%
9/9/2026Integrated Wealth Concepts LLC5,000$39K0.0%-72.1%0.002%
9/9/2026NewEdge Advisors LLC14,852$117K0.0%+4,850.7%0.005%
9/8/2026Allworth Financial LP11,643$91K0.0%-24.4%0.004%
8/26/2026HighTower Advisors LLC107,933$847K0.0%+12.5%0.035%
8/22/2026TD Waterhouse Canada Inc.9,568,149$72.62M0.2%+0.0%3.121%
8/21/2026XML Financial LLC57,025$448K0.0%+35.7%0.019%
8/20/2026Headlands Technologies LLC246,252$1.93M0.2%+34.8%0.080%
8/20/2026Alyeska Investment Group L.P.526,577$4.13M0.0%-79.7%0.172%
8/20/2026Cookson Peirce & Co. Inc.100,000$785K0.0%N/A0.033%
8/19/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC4,317,206$33.89M0.0%-43.0%1.408%
8/19/2026Hsbc Holdings PLC117,930$929K0.0%-17.8%0.038%
8/17/2026Ausdal Financial Partners Inc.15,167$119K0.0%N/A0.005%
8/17/2026Bank of America Corp DE6,141,539$48.21M0.0%N/A2.003%
8/15/2026Man Group plc228,979$1.80M0.0%N/A0.075%
8/14/2026Hsbc Holdings PLC117,930$929K0.0%N/A0.038%
8/14/2026Brandywine Managers LLC28,488$224K0.1%N/A0.009%
8/13/2026Cibc World Market Inc.17,246$135K0.0%N/A0.006%
8/12/2026Quantbot Technologies LP79,955$628K0.0%N/A0.026%
8/11/2026Green Alpha Advisors LLC21,916$172K0.1%N/A0.007%
8/11/2026Allworth Financial LP11,643$91K0.0%N/A0.004%
8/10/2026AssuredPartners Investment Advisors LLC10,187$80K0.0%N/A0.003%
8/7/2026Citizens Financial Group Inc. RI211,890$1.66M0.0%N/A0.069%
8/7/2026BlackRock Inc.3,805,309$29.87M0.0%N/A1.246%
8/7/2026OneDigital Investment Advisors LLC34,000$267K0.0%N/A0.011%
8/7/2026HBK Sorce Advisory LLC26,183$155K0.0%N/A0.009%
8/6/2026State of Wyoming29,928$235K0.0%N/A0.010%
8/6/2026GSA Capital Partners LLP211,370$1.66M0.1%N/A0.069%
7/10/2026Handelsbanken Fonder AB147,900$1.16M0.0%+27.8%0.048%
5/19/2026Bank of America Corp DE2,999,936$10.47M0.0%+13.9%0.982%
5/18/2026Royal Bank of Canada394,753$1.38M0.0%+5.6%0.129%
5/16/2026Lazard Asset Management LLC305,224$1.07M0.0%-7.1%0.100%
5/14/2026Renaissance Technologies LLC1,510,629$5.27M0.0%-36.8%0.495%
5/7/2026SEB Asset Management AB340,267$1.19M0.0%N/A0.111%
4/30/2026Hsbc Holdings PLC143,472$499K0.0%+22.6%0.047%
4/22/2026Janney Montgomery Scott LLC13,043$46K0.0%N/A0.004%
4/22/2026Ground Swell Capital LLC15,820$55K0.1%N/A0.005%
4/16/2026SG Americas Securities LLC20,200$70K0.0%N/A0.007%
3/20/2026Hsbc Holdings PLC117,031$401K0.0%+375.4%0.039%
2/23/2026Virtu Financial LLC181,031$619K0.0%N/A0.060%
First Look: Elon’s “Starphone” (Ad)

Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel

See the full evidence behind Elon Musk's rumored new device.
2/19/2026Invesco Ltd.54,603$187K0.0%+27.9%0.018%
2/18/2026XTX Topco Ltd363,251$1.24M0.0%N/A0.121%
2/18/2026nVerses Capital LLC35,446$121K0.3%N/A0.012%
2/18/2026Voloridge Investment Management LLC695,796$2.38M0.0%+170.0%0.232%
2/18/2026Virtus Investment Advisers LLC73,488$251K0.1%+103.4%0.025%
2/18/2026Tudor Investment Corp ET AL1,796,010$6.14M0.0%+146.0%0.600%
2/18/2026Quadrature Capital Ltd205,095$701K0.0%N/A0.069%
2/18/2026Oxford Asset Management LLP14,875$51K0.0%N/A0.005%
2/18/2026Millennium Management LLC1,773,539$6.07M0.0%-27.0%0.593%
2/18/2026Engineers Gate Manager LP11,203$38K0.0%N/A0.004%
2/17/2026Schonfeld Strategic Advisors LLC19,580$67K0.0%N/A0.007%
2/17/2026Lazard Asset Management LLC328,717$1.12M0.0%-49.6%0.110%
2/17/2026Jump Financial LLC81,271$278K0.0%-88.0%0.027%
2/17/2026Osaic Holdings Inc.347,321$1.19M0.0%+1.2%0.116%
2/17/2026Advisory Services Network LLC29,664$101K0.0%+12.9%0.010%
2/17/2026Softbank Group CORP.345,161$1.18M0.0%N/A0.115%
2/17/2026&PARTNERS10,000$34K0.0%-33.3%0.003%
2/17/2026ExodusPoint Capital Management LP113,068$387K0.0%N/A0.038%
2/17/2026Royal Bank of Canada373,856$1.28M0.0%-25.8%0.125%
2/17/2026Graham Capital Management L.P.257,838$882K0.0%+887.4%0.086%
2/17/2026Magnetar Financial LLC14,264$49K0.0%N/A0.005%
2/16/2026Squarepoint Ops LLC133,069$455K0.0%+29.9%0.044%
2/13/2026Stifel Financial Corp85,169$291K0.0%-17.1%0.028%
2/13/2026Headlands Technologies LLC188,787$646K0.1%+57.9%0.063%
2/13/2026State Street Corp694,114$2.37M0.0%+3.4%0.232%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC7,876,629$26.94M0.0%N/A2.631%
2/12/2026Federation des caisses Desjardins du Quebec39,862$136K0.0%-8.7%0.013%
2/12/2026HRT Financial LP548,431$1.88M0.0%+25.6%0.183%
2/12/2026Commonwealth Equity Services LLC11,757$40K0.0%-22.7%0.004%
2/12/2026Renaissance Technologies LLC2,389,229$8.17M0.0%-28.9%0.798%
2/12/2026Intesa Sanpaolo S.p.A.182,471$617K0.0%N/A0.061%
2/12/2026Bank of Montreal Can146,359$501K0.0%+123.4%0.049%
2/12/2026Polen Capital Management LLC102,508$351K0.0%-61.9%0.034%
2/11/2026LPL Financial LLC48,704$167K0.0%+36.2%0.016%
2/11/2026Tradition Wealth Management LLC47,110$161K0.0%+30.4%0.016%
2/10/2026Cibc World Market Inc.20,706$71K0.0%+26.5%0.007%
2/10/2026Intellectus Partners LLC523,383$1.79M0.3%-3.6%0.175%
2/10/2026Goldman Sachs Group Inc.4,344,485$14.86M0.0%+1,636.3%1.451%
2/10/2026Norges Bank176,386$603K0.0%N/A0.059%
2/9/2026Geode Capital Management LLC313,467$1.07M0.0%-4.8%0.105%
2/9/2026HBK Sorce Advisory LLC24,956$79K0.0%N/A0.008%
2/6/2026Handelsbanken Fonder AB79,300$271K0.0%N/A0.026%
2/6/2026HighTower Advisors LLC79,963$273K0.0%+164.7%0.027%
2/5/2026Allworth Financial LP11,274$39K0.0%+857.0%0.004%
2/4/2026Pier 88 Investment Partners LLC105,730$362K0.1%-2.9%0.035%
2/3/2026Ballentine Partners LLC18,603$64K0.0%-25.6%0.006%
2/3/2026AssuredPartners Investment Advisors LLC10,019$34K0.0%N/A0.003%
1/29/2026UBS Group AG1,939,409$6.63M0.0%-22.1%0.648%
1/29/2026China Universal Asset Management Co. Ltd.48,777$167K0.0%-6.9%0.016%
1/28/2026HB Wealth Management LLC18,981$65K0.0%-34.5%0.006%
A new kind of civil war is coming after election day? (Ad)

Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the political and investment landscape. Whitney Tilson believes tensions may come to a head at midnight on November 4th, the day after the midterm elections, with major implications for your portfolio.tc pixel

Read Whitney Tilson's free analysis on what could happen next.
1/26/2026Mirae Asset Global Investments Co. Ltd.14,546$50K0.0%+25.9%0.005%
1/20/2026Stratos Wealth Advisors LLC23,000$79K0.0%+21.1%0.008%
1/15/2026MOR Wealth Management LLC33,000$113K0.1%N/A0.011%
1/7/2026Green Alpha Advisors LLC27,592$94K0.1%+21.2%0.009%
1/1/2026JPMorgan Chase & Co.130,664$657K0.0%-3.5%0.044%
1/1/2026Tudor Investment Corp ET AL730,122$3.67M0.0%N/A0.244%
12/9/2025Tudor Investment Corp ET AL730,122$3.67M0.0%N/A0.244%
11/18/2025Advisory Services Network LLC26,278$132K0.0%N/A0.009%
11/17/2025Caxton Associates LLP357,506$1.80M0.0%N/A0.119%
11/17/2025Voleon Capital Management LP11,200$56K0.0%N/A0.004%


ABCL Institutional Ownership - Frequently Asked Questions

During the previous two years, 144 institutional investors and hedge funds held shares of AbCellera Biologics. The most heavily invested institutionals were TD Waterhouse Canada Inc. ($72.62M), Baillie Gifford & Co. ($52.43M), Bank of America Corp DE ($48.21M), UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ($33.89M), BlackRock Inc. ($29.87M), Two Sigma Investments LP ($26.03M), and Capital World Investors ($23.25M).Learn more on AbCellera Biologics' institutional investors.

61.42% of AbCellera Biologics' stock is owned by institutional investors. Learn more on ABCL's institutional investor holdings.

Of the 120 institutional investors that purchased AbCellera Biologics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($19.05M), Bank of America Corp DE ($8.91M), Capital World Investors ($7.93M), Goldman Sachs Group Inc. ($4.09M), BlackRock Inc. ($3.81M), Tudor Investment Corp ET AL ($2.53M), and Norges Bank ($2.09M).

Institutional investors have bought a total of 36,693,100 shares in the last 24 months. This purchase volume represents approximately $189.18M in transactions.

Of the 29 institutional investors that sold AbCellera Biologics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ($3.26M), Alyeska Investment Group L.P. ($2.07M), Renaissance Technologies LLC ($1.85M), Millennium Management LLC ($1.62M), UBS Group AG ($1.51M), Jump Financial LLC ($594.33K), and Lazard Asset Management LLC ($346.87K).

Institutional investors have sold a total of 11,889,544 shares in the last 24 months. This volume of shares sold represents approximately $67.90M in transactions.



Institutional ownership data for NASDAQ:ABCL is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners